Amani Therapeutics
AT
Active
Developing highly efficacious, safer medicines.
Amani Therapeutics
Developing highly efficacious, safer medicines.
About
Amani Therapeutics is a biotechnology company focused on developing highly efficacious, safer medicines for people living with various conditions. The company was founded with backing from RTW Investments and has in-licensed a Phase 3-ready novel chemical entity (NCE) from AstraZeneca as part of its lead program, AM-01.
Tags
Score Breakdown
53Traction
37Team
0Visibility
25Profile
0Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Amani Therapeutics do?
Amani Therapeutics is a biotechnology company focused on developing highly efficacious, safer medicines for people living with various conditions. The company was founded with backing from RTW Investments and has in-licensed a Phase 3-ready novel chemical entity (NCE) from AstraZeneca as part of its lead program, AM-01.
How much funding has Amani Therapeutics raised?
Amani Therapeutics has raised a total of $25M in funding. The most recent round on record is Series A.
Where is Amani Therapeutics headquartered?
Amani Therapeutics is headquartered in New York, USA.
What industry does Amani Therapeutics operate in?
Amani Therapeutics operates in Biotechnology, Pharmaceuticals, Healthcare.